Tritrichomonas Infection in the Uterus of a Cat

Dahlgren, S. S., B. Gjerde, et al. (2007). "First record of natural Tritrichomonas foetus infection of the feline uterus." J Small Anim Pract 48(11): 654-7.

Tritrichomonas foetus is an emerging intestinal parasite of cats, causing chronic large bowel diarrhea. In cattle, this protozoan parasite is a sexually transmitted pathogen, infecting the uterus of cows and the preputial cavity and urethral orifice of bulls. In this case report, the first feline record of T. foetus infection of the uterus is described in a 17-month old Exotic Shorthair queen in Norway with pyometra. This queen had no history of diarrhea. Three other cats in the cattery were diagnosed with T. foetus infection using PCR on fecal samples: a 4.5-year old Persian male with intermittent diarrhea, a 22-month old male Exotic Shorthair with normal feces, and a 2.5-year old female Persian with normal feces. Interestingly, T. foetus has never been identified in cattle in Norway, although it is a reportable disease.
>> PubMed abstract


Related articles:
Winn funded research
Kather, E. J., S. L. Marks, et al. (2007). "Determination of the in vitro susceptibility of feline Tritrichomonas foetus to 5 antimicrobial agents." J Vet Intern Med 21(5): 966-70.
>> PubMed abstract


More on cat health: Winn Feline Foundation Library

Dahlgren, S. S., B. Gjerde, et al. (2007). "First record of natural Tritrichomonas foetus infection of the feline uterus." J Small Anim Pract 48(11): 654-7.

Tritrichomonas foetus is an emerging intestinal parasite of cats, causing chronic large bowel diarrhea. In cattle, this protozoan parasite is a sexually transmitted pathogen, infecting the uterus of cows and the preputial cavity and urethral orifice of bulls. In this case report, the first feline record of T. foetus infection of the uterus is described in a 17-month old Exotic Shorthair queen in Norway with pyometra. This queen had no history of diarrhea. Three other cats in the cattery were diagnosed with T. foetus infection using PCR on fecal samples: a 4.5-year old Persian male with intermittent diarrhea, a 22-month old male Exotic Shorthair with normal feces, and a 2.5-year old female Persian with normal feces. Interestingly, T. foetus has never been identified in cattle in Norway, although it is a reportable disease.
>> PubMed abstract


Related articles:
Winn funded research
Kather, E. J., S. L. Marks, et al. (2007). "Determination of the in vitro susceptibility of feline Tritrichomonas foetus to 5 antimicrobial agents." J Vet Intern Med 21(5): 966-70.
>> PubMed abstract


More on cat health: Winn Feline Foundation Library

Read More

Quality of Life for Cats Receiving Chemotherapy

Tzannes, S., M. F. Hammond, et al. (2008). "Owners 'perception of their cats' quality of life during COP chemotherapy for lymphoma." J Feline Med Surg 10(1): 73-81.


Lymphoma is one of the most common feline cancers and many owners opt for chemotherapy as a treatment option. Most owners are concerned about quality of life for feline cancer patients, both with and without chemotherapy. Questionnaires on quality of life (QOL) were completed by the owners of 31 cats undergoing treatment for lymphoma between 2002 and 2006. All cats were treated with cyclophosphamide, vincristine, and prednisolone (COP). QOL scores were significantly higher in cats before the onset of cancer than after, but before the start of chemotherapy. During chemotherapy, QOL scores were also lower than before the onset of cancer, but were significantly higher than prior to starting treatment. The majority of cats (87%) experienced adverse effects during treatment. Most pet owners (83%) were happy they treated their cats and most (87%) would treat another cat. The results of this questionnaire survey indicate that COP chemotherapy is well tolerated by cats according to owner perceptions of QOL.
>> PubMed abstract


Related articles:
Teske, E., G. van Straten, et al. (2002). "Chemotherapy with cyclophosphamide, vincristine, and prednisone (COP) in cats with malignant lymphoma: new results with an old protocol." J Vet Intern Med 16(2): 179-186.
>> PubMed abstract


More on cat health: Winn Feline Foundation

Tzannes, S., M. F. Hammond, et al. (2008). "Owners 'perception of their cats' quality of life during COP chemotherapy for lymphoma." J Feline Med Surg 10(1): 73-81.


Lymphoma is one of the most common feline cancers and many owners opt for chemotherapy as a treatment option. Most owners are concerned about quality of life for feline cancer patients, both with and without chemotherapy. Questionnaires on quality of life (QOL) were completed by the owners of 31 cats undergoing treatment for lymphoma between 2002 and 2006. All cats were treated with cyclophosphamide, vincristine, and prednisolone (COP). QOL scores were significantly higher in cats before the onset of cancer than after, but before the start of chemotherapy. During chemotherapy, QOL scores were also lower than before the onset of cancer, but were significantly higher than prior to starting treatment. The majority of cats (87%) experienced adverse effects during treatment. Most pet owners (83%) were happy they treated their cats and most (87%) would treat another cat. The results of this questionnaire survey indicate that COP chemotherapy is well tolerated by cats according to owner perceptions of QOL.
>> PubMed abstract


Related articles:
Teske, E., G. van Straten, et al. (2002). "Chemotherapy with cyclophosphamide, vincristine, and prednisone (COP) in cats with malignant lymphoma: new results with an old protocol." J Vet Intern Med 16(2): 179-186.
>> PubMed abstract


More on cat health: Winn Feline Foundation

Read More

Spironolactone in Cats With Heart Disease

Macdonald, K. A., M. D. Kittleson, et al. (2008). "Effect of spironolactone on diastolic function and left ventricular mass in Maine Coon cats with familial hypertrophic cardiomyopathy." J Vet Intern Med 22(2): 335-41.

Hypertrophic cardiomyopathy (HCM) is a primary myocardial disease affecting the left ventricle. Some of the pathologic abnormalities found in HCM are myocardial fibrosis and concentric hypertrophy. Treatments that would reverse these pathologic changes would be beneficial. In a rat model of HCM, spironolactone reversed interstitial fibrosis, decreased myocyte disarray by 50%, and improved diastolic function within 10 weeks of treatment. The goal of this study was to evaluate spironolactone treatment of Maine Coon cats with HCM for its ability to improve diastolic function and reduce left ventricular mass. The study enrolled 26 Maine Coon cats with familial HCM and randomized them into two groups. One group received spironolactone (2 mg/kg, PO, BID) and the other group received placebo for 4 months. No significant treatment effect on cardiac function or left ventricular mass was identified. Severe facial dermatitis developed in 4 of the 13 cats receiving spironolactone, requiring discontinuation of therapy.

>> PubMed abstract

Related articles:

Winn funded research

Meurs, K., X. Sanchez, et al. (2005). "A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy." Hum Mol Genet 14(23): 3587-3593.

>> PubMed abstract

More on cat health: Winn Feline Foundation Library

Macdonald, K. A., M. D. Kittleson, et al. (2008). "Effect of spironolactone on diastolic function and left ventricular mass in Maine Coon cats with familial hypertrophic cardiomyopathy." J Vet Intern Med 22(2): 335-41.

Hypertrophic cardiomyopathy (HCM) is a primary myocardial disease affecting the left ventricle. Some of the pathologic abnormalities found in HCM are myocardial fibrosis and concentric hypertrophy. Treatments that would reverse these pathologic changes would be beneficial. In a rat model of HCM, spironolactone reversed interstitial fibrosis, decreased myocyte disarray by 50%, and improved diastolic function within 10 weeks of treatment. The goal of this study was to evaluate spironolactone treatment of Maine Coon cats with HCM for its ability to improve diastolic function and reduce left ventricular mass. The study enrolled 26 Maine Coon cats with familial HCM and randomized them into two groups. One group received spironolactone (2 mg/kg, PO, BID) and the other group received placebo for 4 months. No significant treatment effect on cardiac function or left ventricular mass was identified. Severe facial dermatitis developed in 4 of the 13 cats receiving spironolactone, requiring discontinuation of therapy.

>> PubMed abstract

Related articles:

Winn funded research

Meurs, K., X. Sanchez, et al. (2005). "A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy." Hum Mol Genet 14(23): 3587-3593.

>> PubMed abstract

More on cat health: Winn Feline Foundation Library

Read More

Cytauxzoonosis in Domestic Cats

Reichard, M. V., K. A. Baum, et al. (2008). "Temporal occurrence and environmental risk factors associated with cytauxzoonosis in domestic cats." Vet Parasitol 152(3-4): 314-20.

Cytauxzoonosis is caused by Cytauxzoon felis, a protozoan parasite of domestic and wild cats that is transmitted by ticks. The disease is seen in the south-central and southeastern U.S. Cytauxzoonosis is typically a severe disease in domestic cats, with fever , anorexia, anemia, and icterus. Most affected cats die within 3 weeks. This study determined the temporal occurrence and risk factors associated with C. felis infection in domestic cats in Oklahoma with a retrospective search of electronic medical records from the Oklahoma Animal Disease Diagnostic Laboratory and the Boren Veterinary Medical Teaching Hospital. From 1995 to 2006, a total of 232 cytauxzoonosis cases were identified and analyzed. The number of cases remained constant from year to year. Diagnosis of the disease followed a bimodal pattern, with most cases diagnosed in April-June and a smaller number in August-September. In cases where a client address was known, the majority occurred in low density residential areas. Cytauxzoonosis cases were significantly associated with more wooded cover and closer proximity to natural or unmanaged areas than control sites. More cases can be expected in domestic cats living in close proximity to environments that support both ticks and bobcats.
>> PubMed abstract

Related articles:
Haber, M. D., M. D. Tucker, et al. (2007). "The detection of Cytauxzoon felis in apparently healthy free-roaming cats in the USA." Vet Parasitol 146(3-4): 316-20.
>> PubMed abstract

Birkenheuer, A., J. Le, et al. (2006). "Cytauxzoon felis infection in cats in the mid-Atlantic states: 34 cases (1998-2004)." J Amer Vet Med Assoc 228(4): 568-571.
>> PubMed abstract

More on cat health: Winn Feline Foundation Library

Reichard, M. V., K. A. Baum, et al. (2008). "Temporal occurrence and environmental risk factors associated with cytauxzoonosis in domestic cats." Vet Parasitol 152(3-4): 314-20.

Cytauxzoonosis is caused by Cytauxzoon felis, a protozoan parasite of domestic and wild cats that is transmitted by ticks. The disease is seen in the south-central and southeastern U.S. Cytauxzoonosis is typically a severe disease in domestic cats, with fever , anorexia, anemia, and icterus. Most affected cats die within 3 weeks. This study determined the temporal occurrence and risk factors associated with C. felis infection in domestic cats in Oklahoma with a retrospective search of electronic medical records from the Oklahoma Animal Disease Diagnostic Laboratory and the Boren Veterinary Medical Teaching Hospital. From 1995 to 2006, a total of 232 cytauxzoonosis cases were identified and analyzed. The number of cases remained constant from year to year. Diagnosis of the disease followed a bimodal pattern, with most cases diagnosed in April-June and a smaller number in August-September. In cases where a client address was known, the majority occurred in low density residential areas. Cytauxzoonosis cases were significantly associated with more wooded cover and closer proximity to natural or unmanaged areas than control sites. More cases can be expected in domestic cats living in close proximity to environments that support both ticks and bobcats.
>> PubMed abstract

Related articles:
Haber, M. D., M. D. Tucker, et al. (2007). "The detection of Cytauxzoon felis in apparently healthy free-roaming cats in the USA." Vet Parasitol 146(3-4): 316-20.
>> PubMed abstract

Birkenheuer, A., J. Le, et al. (2006). "Cytauxzoon felis infection in cats in the mid-Atlantic states: 34 cases (1998-2004)." J Amer Vet Med Assoc 228(4): 568-571.
>> PubMed abstract

More on cat health: Winn Feline Foundation Library

Read More